These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9449572)

  • 1. High-performance liquid chromatographic determination of pyrazoloacridine, a nitro-9-methoxyacridine anticancer agent, in human plasma.
    Jayewardene AL; Santoro JE; Gambertoglio JG
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):203-10. PubMed ID: 9449572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
    Berg SL; Blaney SM; Adamson PC; O'Brien M; Poplack DG; Arndt C; Blatt J; Balis FM
    J Clin Oncol; 1998 Jan; 16(1):181-6. PubMed ID: 9440741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and antitumor activity of a reduction product in the murine metabolism of pyrazoloacridine (NSC-366140).
    Palomino E; Foster B; Kempff M; Corbett T; Wiegand R; Horwitz J; Baker L
    Cancer Chemother Pharmacol; 1996; 38(5):453-8. PubMed ID: 8765439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
    Grem JL; Harold N; Keith B; Chen AP; Kao V; Takimoto CH; Hamilton JM; Pang J; Pace M; Jasser GB; Quinn MG; Monahan BP
    Clin Cancer Res; 2002 Jul; 8(7):2149-56. PubMed ID: 12114415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.
    Bullen WW; Whitfield LR; Walter GA; Brodfuehrer JI
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):141-51. PubMed ID: 7550971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma.
    Jayewardene AL; Zhu F; Aweeka FT; Gambertoglio JG
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):203-11. PubMed ID: 9613951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
    Frank SK; Mathiesen DA; Whitfield LR; Ames MM
    J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation of solid phase extraction to an automated column switching method for online sample cleanup as the basis of a facile and sensitive high-performance liquid chromatographic assay for paclitaxel in human plasma.
    Supko JG; Nair RV; Seiden MV; Lu H
    J Pharm Biomed Anal; 1999 Dec; 21(5):1025-36. PubMed ID: 10703971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
    Adjei AA; Reid JM; Erlichman C; Sloan JA; Pitot HC; Alberts SR; Goldberg RM; Hanson LJ; Ruben S; Boemer SA; Atherton P; Ames MM; Kaufmann SH
    Invest New Drugs; 2002 Aug; 20(3):297-304. PubMed ID: 12201492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).
    LoRusso P; Foster BJ; Poplin E; McCormick J; Kraut M; Flaherty L; Heilbrun LK; Valdivieso M; Baker L
    Clin Cancer Res; 1995 Dec; 1(12):1487-93. PubMed ID: 9815948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pyrazoloacridine in the rhesus monkey.
    Berg SL; Balis FM; McCully CL; Godwin KS; Poplack DG
    Cancer Res; 1991 Oct; 51(20):5467-70. PubMed ID: 1913666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of the anticancer drug oxantrazole in rat whole blood and tissues.
    Hassan EE; Gallo JM
    J Chromatogr; 1992 Nov; 582(1-2):225-31. PubMed ID: 1491045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.
    Rowinsky EK; Noe DA; Grochow LB; Sartorious SE; Bowling MK; Chen TL; Lubejko BG; Kaufmann SH; Donehower RC
    J Clin Oncol; 1995 Aug; 13(8):1975-84. PubMed ID: 7636538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the anticancer drug KW-2170, a pyrazoloacridone derivative, and its metabolites in human and dog plasma by high-performance liquid chromatography using an electrochemical detector.
    Kuramitsu T; Takai K; Ohashi R; Kuwabara T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 768(2):231-7. PubMed ID: 11888050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
    Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
    Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma.
    Kim HK; Lin CC; Parker D; Veals J; Lim J; Likhari P; Statkevich P; Marco A; Nomeir AA
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):225-33. PubMed ID: 9448080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography.
    Campanero MA; Sadaba B; García-Quetglas E; Azanza JR
    J Chromatogr B Biomed Sci Appl; 1998 Mar; 706(2):311-7. PubMed ID: 9551818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid liquid chromatographic method for the determination of lamotrigine in plasma.
    Matar KM; Nicholls PJ; Bawazir SA; al-Hassan MI; Tekle A
    J Pharm Biomed Anal; 1998 Jul; 17(3):525-31. PubMed ID: 9656165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ; Wiegand RA; LoRusso PM; Baker LH
    Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.